Barcelona, Spain Nov 13, 2019 (Issuewire.com) - Journal of Leukemia is a peer-reviewed Open Access journal that publishes original research and review articles includes a wide range of fields in Leukemia, Multiple Myeloma, Acute Lymphoblastic Leukemia, Acute Myleoid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myleloid Leukemia, Hairy Cell Leukemia, Pediatric Leukemia, Leukemia drugs, Stem Cell Transplant, Plasma cell Leukemia, Mast cell Leukemia, Lymphoma Cancer, Lymphoma Symptoms, Spleen Cancer, Acute Myelomonocytic Leukemia, Aleukemic Leukemia , Lymphosarcoma, Megakaryocytic Leukemia, Feline Leukemia complex. The journal publishes papers on Leukemia and treatment for Leukemia, Leukemia drugs and clinical trials. The journal also welcomes preclinical and clinical trials of drugs that can closely related to Lymphoma.
Journal of Leukemia Research operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. For more information on Article Processing charges in general, click here. Archived online in the transactions of the Longdom Publishing SL, which provides the international scientific community with immediate and permanent access to individual papers.
JLU Research is archived in Index Copernicus, SHERP RoMEO AND Open J Gate which provides permanent archiving for electronic scholarly journals.
JLU Research was founded in 2013. Tadeusz Robak as the Editor-in-Chief of the journal.
Media Contact
LONGDOM leukemia@longdomjournals.org +34 911 877 608 leukemia@longdomjournals.org https://www.longdom.org/leukemia/aims-and-scope.html
